국소 마취 시장 규모 : 약물 유형, 투여 경로, 용도 및 최종 용도별 세계 예측(2024-2032년)

Local anesthesia market size is projected to expand at 4.2% CAGR from 2024 to 2032, due to the rising number of surgical procedures across various medical specialties, coupled with the expanding aging population requiring pain management. The higher technological advancements, such as the development of long-acting and less invasive anesthesia techniques is leading to enhanced patient comfort and satisfaction.

Additionally, the increasing prevalence of chronic pain conditions and dental procedures will accelerate the product adoption. Lately, there has been growing awareness among healthcare professionals about the benefits of local anesthesia in minimizing systemic side effects and accelerating patient recovery. The ongoing research and innovation in drug formulations and delivery methods will also continue to benefit the industry growth. For instance, in December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection, intended for use in surgeries, dental and oral procedures, diagnostic and therapeutic procedures, as well as obstetrical procedures.

The local anesthesia industry is categorized into drug type, route of administration, application, end-use, and region.

With respect to drug type, the industry share from the articaine drug segment is estimated to rise at 4.3% CAGR from 2024 to 2032. The growth can be ascribed to the rapid onset and prolonged duration of articaine for enhancing efficacy in dental and medical procedures. Moreover, the increasing preference for articaine due to its effectiveness in pain management and improved patient outcomes will contribute to the product demand.

Local anesthesia market share from the obstetrics and gynecology application segment is projected record 4% CAGR from 2024 to 2032. This is due to the increasing use of local anesthesia for pain management during various gynecological procedures and obstetric interventions. In addition, the rising emphasis on improving patient comfort and minimizing systemic side effects will boost the segment growth.

Regionally, the Europe local anesthesia market is projected to depict 4.3% CAGR from 2024 to 2032. The growth can be attributed to the rise in surgical procedures, aging population, and increased awareness of the benefits of local anesthesia. The rising advancements in healthcare infrastructure coupled with the strong focus on patient-centric care will also drive the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Local anesthesia industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Drug type trends
  • 2.1.4 Route of administration trends
  • 2.1.5 Application trends
  • 2.1.6 End-use trends

Chapter 3 Local Anesthesia Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising geriatric population
    • 3.2.1.2 Increasing number of surgical procedures
    • 3.2.1.3 Increasing preference for local anesthetics over opioids
    • 3.2.1.4 Advancement in drug delivery drives the demand
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Dose dependent side effects and limited duration of action
    • 3.2.2.2 Stringent regulatory complexities
• 3.3 Growth potentialanalysis
  • 3.3.1 By drug type
  • 3.3.2 By route of administration
  • 3.3.3 By application
  • 3.3.4 By end-use
• 3.4 Regulatory landscape
• 3.5 Pipelineanalysis
• 3.6 Porter'sanalysis
• 3.7 PESTELanalysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrixanalysis, 2023
• 4.3 Competitiveanalysis of major market players, 2023
• 4.4 Competitive positioning matrix, 2023
• 4.5 Strategic dashboard, 2023

Chapter 5 Local Anesthesia Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)

• 5.1 Key trends, by drug type
• 5.2 Lidocaine
• 5.3 Bupivacaine
• 5.4 Ropivacaine
• 5.5 Prilocaine
• 5.6 Articaine
• 5.7 Other drug types

Chapter 6 Local Anesthesia Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

• 6.1 Key trends, by route of administration
• 6.2 Topical
• 6.3 Injectable

Chapter 7 Local Anesthesia Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Dental
• 7.3 Obstetrics and gynecology
• 7.4 Emergency medicine
• 7.5 Dermatological procedures
• 7.6 Other applications

Chapter 8 Local Anesthesia Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)

• 8.1 Key trends, by end-use
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Dental clinics
• 8.5 Other end-users

Chapter 9 Local Anesthesia Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Pfizer Inc.
• 10.2 GE Healthcare
• 10.3 Baxter International Inc.
• 10.4 Fresenius Kabi
• 10.5 B. Braun Melsungen AG
• 10.6 Piramal
• 10.7 AbbVie Inc.
• 10.8 Pacira BioSciences
• 10.9 Aspen Pharmacare Holdings Ltd
• 10.10 Septodont
• 10.11 Ultracain